Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy
Sponsor
Far Eastern Memorial Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05969405
Collaborator
(none)
400
1
17.8
22.4
Study Details
Study Description
Brief Summary
Objective：To compare the clinical outcomes of endometrial cancer patients who received surgerical treatments: Comparisons of robotic-assisted laparoscopic, laparoscopic and laparotomic methods
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
We will review the medical records of clinically uterine-confined endometrial cancer women who received robotic-assisted laparoscopic, laparoscopic or laparotomic methods; and compare their outcomes.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
400 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy
Actual Study Start Date
:
Jul 7, 2023
Anticipated Primary Completion Date
:
Dec 31, 2024
Anticipated Study Completion Date
:
Dec 31, 2024
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Laparoscopy Laparoscopic staging group |
Procedure: Laparoscopic staging
Laparoscopic staging
|
| Robotic Robotic staing group |
Procedure: Robotic staging
Robotic staging
|
| Laparotomic Laparotomic group |
Procedure: Laparotomic staging
Laparotomic staging
|
Outcome Measures
Primary Outcome Measures
- Overall survival [5 years]
Overall survival
Secondary Outcome Measures
- Progression free survival [5 years]
Progression free survival
- length of hospital stay [2 weeks]
length of hospital stay
- surgical time [1 day]
surgical time
- Estimate blood loss [1 day]
Estimate blood loss
- lymph node number [1 day]
dissected lymph node number
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- womwn who received endometrial cancer surgical from January 01, 2008 to November 30, 2022 were be reviewed.
Exclusion Criteria:
- Endometrial cancer patients did not undergo surgery.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital | Banqiao | New Taipei | Taiwan | 22050 |
Sponsors and Collaborators
- Far Eastern Memorial Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Sheng-Mou Hsiao,
Chief, Department of Obstetrics & Gynecology,
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT05969405
Other Study ID Numbers:
- 112002-E
First Posted:
Aug 1, 2023
Last Update Posted:
Aug 1, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: